Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Radioactive iodine offers survival improvement in patients with follicular carcinoma of the thyroid.

Podnos YD, Smith D, Wagman LD, Ellenhorn JD.

Surgery. 2005 Dec;138(6):1072-6; discussion 1076-7.

PMID:
16360393
2.

Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.

Podnos YD, Smith DD, Wagman LD, Ellenhorn JD.

J Surg Oncol. 2007 Jul 1;96(1):3-7.

PMID:
17567872
3.

The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer.

Podnos YD, Smith D, Wagman LD, Ellenhorn JD.

Am Surg. 2005 Sep;71(9):731-4.

PMID:
16468507
4.

[Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].

Liu WS, Qi YF, Tang PZ.

Ai Zheng. 2004 Sep;23(9):1081-4. Chinese.

PMID:
15363207
5.
6.

Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.

Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, Sherman SI.

Cancer. 2003 Mar 1;97(5):1186-94.

7.

The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.

Zaydfudim V, Feurer ID, Griffin MR, Phay JE.

Surgery. 2008 Dec;144(6):1070-7; discussion 1077-8. doi: 10.1016/j.surg.2008.08.034.

PMID:
19041020
8.
9.

Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.

Asari R, Koperek O, Scheuba C, Riss P, Kaserer K, Hoffmann M, Niederle B.

Ann Surg. 2009 Jun;249(6):1023-31. doi: 10.1097/SLA.0b013e3181a77b7b.

PMID:
19474675
10.

Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.

Cappelli C, Pirola I, Braga M, De Martino E, Morassi ML, Gandossi E, Mattanza C, Balzano R, Castellano M, Rosei EA.

Ann Ital Chir. 2006 Mar-Apr;77(2):107-13.

PMID:
17147082
11.

Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.

Handkiewicz-Junak D, Wloch J, Roskosz J, Krajewska J, Kropinska A, Pomorski L, Kukulska A, Prokurat A, Wygoda Z, Jarzab B.

J Nucl Med. 2007 Jun;48(6):879-88.

12.

Follicular thyroid carcinoma: prognostic factors and the role of radioiodine.

Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Lau WH.

Cancer. 2002 Aug 1;95(3):488-98.

13.

Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.

Chen PV, Osborne R, Ahn E, Avitia S, Juillard G.

Ear Nose Throat J. 2009 Jul;88(7):E01.

PMID:
19623515
14.

Treatment for microcarcinoma of the thyroid--clinical experience.

Küçük NO, Tari P, Tokmak E, Aras G.

Clin Nucl Med. 2007 Apr;32(4):279-81.

PMID:
17413573
15.

Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.

Lin JD, Chao TC, Chen ST, Huang YY, Liou MJ, Hsueh C.

Surg Oncol. 2007 Aug;16(2):107-13. Epub 2007 Jun 27.

PMID:
17600699
16.

Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.

Sacks W, Wong RM, Bresee C, Braunstein GD.

Thyroid. 2015 Apr;25(4):377-85. doi: 10.1089/thy.2014.0298. Epub 2015 Feb 6.

PMID:
25578116
17.

Localized well-differentiated thyroid carcinoma: survival analysis of prognostic factors and (131)I therapy.

Morris DM, Boyle PJ, Stidley CA, Altobelli KK, Parnell T, Key C.

Ann Surg Oncol. 1998 Jun;5(4):329-37.

PMID:
9641454
19.

Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases.

Rao RS, Parikh HK, Deshmane VH, Parikh DM, Shrikhande SS, Havaldar R.

Head Neck. 1996 Mar-Apr;18(2):118-24; discussion 124-6.

PMID:
8647676
20.

Differentiated thyroid carcinoma in a juvenile patient.

Khan MU, Nawaz MK, Saadullah M, Syed AA, Hussain R, Azhar R, Shah MA.

Clin Nucl Med. 2008 May;33(5):319-20. doi: 10.1097/RLU.0b013e31816a7944.

PMID:
18431142

Supplemental Content

Support Center